Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

PURPOSE: Recent advances in nonmyeloablative (NMA), related HLA-haploidentical blood or marrow transplantation (haplo-BMT) have expanded the donor pool. This study evaluated the effect of age on NMA haplo-BMT outcomes in patients age 50 to 75 years. PATIENTS AND METHODS: A retrospective analysis was...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Oncol
Egile Nagusiak: Kasamon, Yvette L., Bolaños-Meade, Javier, Prince, Gabrielle T., Tsai, Hua-Ling, McCurdy, Shannon R., Kanakry, Jennifer A., Rosner, Gary L., Brodsky, Robert A., Perica, Karlo, Smith, B. Douglas, Gladstone, Douglas E., Swinnen, Lode J., Showel, Margaret M., Matsui, William H., Huff, Carol Ann, Borrello, Ivan, Pratz, Keith W., McDevitt, Michael A., Gojo, Ivana, Dezern, Amy E., Shanbhag, Satish, Levis, Mark J., Luznik, Leo, Ambinder, Richard F., Fuchs, Ephraim J., Jones, Richard J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2015
Gaiak:
ORIGINAL REPORTS
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582145/
https://ncbi.nlm.nih.gov/pubmed/26261255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.60.4777
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak